α-L-Talofuranuronic acid, 1-deoxy-5-O-[2,3-di-O-benzoyl-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, methyl ester, 2-benzoate (9CI),360772-38-9-Amadis Chemical-Amadis Chemical

Accueil > Catalogue de produits > sciences de la vie > nucléoside > α-L-Talofuranuronic acid, 1-deoxy-5-O-[2,3-di-O-benzoyl-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, methyl ester, 2-benzoate (9CI)

[CAS No.360772-38-9] A1255151 α-L-Talofuranuronic acid, 1-deoxy-5-O-[2,3-di-O-benzoyl-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, methyl ester, 2-benzoate (9CI) 97%

Rechercher après modification

Numéro de catalogue: A1255151

Cas No.: 360772-38-9

Formule moléculaire: C₄₆H₄₆N₄O₁₆

Masse moléculaire: 910.87

MDL No:

EINECS:

Commande/demande de devis/Support technique

Téléphone: 0086-571-89925085
passer commande & demande de renseignements: sales@amadischem.com
support technique: tech@amadischem.com

Demande groupée

*Tous les produits chimiques de notre société sont réservés à un usage en laboratoire et à des fins de fabrication.

contrôle qualité [360772-38-9]

NMR

CNMR

HPLC

LC-MS

documents connexes [360772-38-9]

SDS

Specification

MOL

SDF

Informations de base [360772-38-9]

Synonymes: α-L-Talofuranuronic acid, 1-deoxy-5-O-[2,3-di-O-benzoyl-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, methyl ester, 2-benzoate (9CI)

Aspect:

Point de fusion:

Point d’ébullition:

Point d'éclair:

Conditions de stockage: Store in 2-8°C for long term (months)

Pubchem ID:

Smiles: O(C(=O)C1=CC=CC=C1)[C@H]2[C@@H](O[C@]([C@@H](O[C@@H]3[C@@H](OC(=O)C4=CC=CC=C4)[C@@H](OC(=O)C5=CC=CC=C5)C=C(C(N[C@H]6CCC[C@@H](C)NC6=O)=O)O3)C(OC)=O)([C@H]2OC)[H])N7C(=O)NC(=O)C=C7

Inchi: InChI=1S/C46H46N4O16/c1-25-14-13-21-29(38(52)47-25)48-39(53)31-24-30(61-41(54)26-15-7-4-8-16-26)33(64-42(55)27-17-9-5-10-18-27)45(62-31)66-37(44(57)60-3)35-34(59-2)36(65-43(56)28-19-11-6-12-20-28)40(63-35)50-23-22-32(51)49-46(50)58/h4-12,15-20,22-25,29-30,33-37,40,45H,13-14,21H2,1-3H3,(H,47,52)(H,48,53)(H,49,51,58)/t25-,29+,30+,33+,34-,35+,36-,37-,40-,45-/m1/s1

InchiKey: DLKFGGRKIIXGOH-MJKUUBDISA-N

Informations de sécurité [360772-38-9]

Pictogramme:

Mot de signalement: Warning

UN No.:

Catégorie de danger:

Classe d'emballage:

Mentions de danger: H302;H315;H319;H332;H335

Conseils de prudence: P261;P280;P305+P351+P338

Littérature associée [360772-38-9]

Désolé, aucune littérature correspondante

Produits similaires [360772-38-9]

A1255462 360772-37-8

α-L-Talofuranuronamide, 1-deoxy-5-O-[2,3-di-O-benzoyl-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-benzoate (9CI)

Reason:nucléoside

A1255391 1158951-70-2

α-L-Talofuranuronamide, 1-deoxy-5-O-[2,3-di-O-acetyl-4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-acetate (ACI)

Reason:nucléoside

A1255370 613244-97-6

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-heptadecanoate (9CI)

Reason:nucléoside

A1255378 360772-35-6

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-2,3-O-(1-methylethylidene)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-[3,4-dihydro-3-[[(4-methoxyphenyl)methoxy]methyl]-2,4-dioxo-1(2H)-pyrimidinyl]-2-O-hexyl-3-O-methyl- (9CI)

Reason:nucléoside

A1255379 360772-31-2

Reason:nucléoside

A1255359 254449-38-2

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-3-O-(1-oxohexadecyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)

Reason:nucléoside

A1255360 254449-37-1

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-3-O-(1-oxopentadecyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)

Reason:nucléoside

A1255361 254449-36-0

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-3-O-(1-oxotetradecyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)

Reason:nucléoside

A1255362 254449-35-9

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-3-O-(1-oxododecyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)

Reason:nucléoside

A1255363 254449-34-8

α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-3-O-(1-oxodecyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)

Reason:nucléoside

Détails du produit [360772-38-9]

Désolé, aucun détail sur le produit

Historique de navigation